Sulfated bile acid is a host-derived ligand for MAIT cells. Ito E, Inuki S, Izumi Y, Takahashi M, Dambayashi Y, Ciacchi L, Awad W, Takeyama A, Shibata K, Mori S, Mak JYW, Fairlie DP, Bamba T, Ishikawa E, Nagae M, Rossjohn J, Yamasaki S.
Sci Immunol. 2024 Jan 26;9(91):eade6924.
New paper published:
"HDAC7 is an immunometabolic switch triaging danger signals for engagement of antimicrobial versus inflammatory responses in macrophages".
January 17, 2023
120 (4) e2212813120
https://t.co/yZaG5C5Q9U
Welcome back to Damica Laurie who is returning to the Fairlie Group as a PhD student. Damica recently completed her Honours Degree (achieving First Class Honours) with us.
That’s a wrap on #CIPPS2022 👏
Thank you to everyone who made it such a fantastic meeting! We feel so inspired by the great peptide and protein science that was shared and we can’t wait to see what’s next 👀
Now we have @FairlieGroup speaking about strategies for programming peptides for cell permeability and bioavailability
If we could reliably get peptides into cells and send them to specific targets, the application possibilities would be endless!
#CIPPS2022
Great to see this paper on stapled peptides out in RSC Chemical Biology. Glad to have played a small part in this work from my time @FairlieGroup.
We investigated how crosslinks affect helicity, protein affinity, proteolytic stability and cell uptake.
https://t.co/viJPsTNF3R
Prof. David Fairlie awarded NHMRC Investigator Grant for discovering drugs that target key protein-protein interactions in cancer, metabolic and inflammatory diseases.
Pleased to share our new paper - a review on our synthesis and development of ligands that modulate #MR1 and #MAIT cells in Accounts of Chemical Research @ACSPublications@FairlieGroup@IMBatUQ @CellsMait #ozchem
https://t.co/ZcVVkz7rhu
New Fairlie Group paper makes the cover of ChemBiochem. Late-Stage Hydrocarbon Conjugation and Cyclisation in Synthetic Peptides and Proteins (ChemBioChem 10/2021)
Dr. Aline D. de Araujo, Huy T. Nguyen, Prof. David P. Fairlie
First published: 19 May 2021 https://t.co/mBG11GN26B
Our new #MR1 study with H McWilliam & J Villadangos, via new tools and techniques incl. a stable fluorescent ligand, conformation specific Ab, and genome-wide CRISPR screen #MAIT#ozchem@FairlieGroup@IMBatUQ @ImagingCoE
@TheDohertyInst@Bio21Institute
https://t.co/bCPu8XxrkO
New research from
@FairlieGroup
shows the potential of a new inhibitor combination in the fight against #cancer. #IMB#2020IMB
Discover more: https://t.co/9t7s9jZ1aB
New research from @FairlieGroup shows the potential of a new inhibitor combination in the fight against #cancer. #IMB#2020IMB
Discover more: https://t.co/rV7YT7M6Zk